Cytokine-Based Immuno-Gene Therapy for Brain Tumors
作者： Roberta P. Glick , Terry Lichtor , Edward P. Cohen
DOI: 10.1007/978-1-59259-035-3_13
关键词: Biology 、 Major histocompatibility complex 、 Immunology 、 Function (biology) 、 White (mutation) 、 Immune system 、 Glioma cell 、 Cytokine 、 Genetic enhancement
摘要: The function of the immune system is to protect body. Leukocytes (white blood cells) and a number accessory cells distributed throughout body perform this defensive function. Lymphocytes are key controlling response (IR). They specifically recognize foreign material distinguish it from body’s own components. But an old concept, new model by Fuchs Matzinger (1) presented below.
springer.com
sci-hub.st 参考文章(40)
Herrlinger U, Breakefield Xo, Reznikoff G, Kramm Cm, Louis Dn, Finkelstein D, Yu Js, Dranoff G, Johnston Km, Vaccination for experimental gliomas using GM-CSF-transduced glioma cells. Cancer Gene Therapy. ,vol. 4, pp. 345- ,(1997)
William A. Robinson, Kathleen Jobe, Richie Stevens, Central nervous system metastases in malignant melanoma Springer US. pp. 155- 163 ,(1987) , 10.1007/978-1-4613-2043-2_8
Zvi Ram, Stuart Walbridge, John D. Heiss, Kenneth W. Culver, R. Michael Blaese, Edward H. Oldfield, In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors Journal of Neurosurgery. ,vol. 80, pp. 535- 540 ,(1994) , 10.3171/JNS.1994.80.3.0535
S Ostrand-Rosenberg, V Clements, A Thakur, Rejection of mouse sarcoma cells after transfection of MHC class II genes. Journal of Immunology. ,vol. 144, pp. 4068- 4071 ,(1990)
K M Hui, T T Foo, T Sim, A A Oei, Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene. Journal of Immunology. ,vol. 143, pp. 3835- 3843 ,(1989)
Martuza Rl, Tepper Ri, Wei Mx, Yu Js, Chiocca Ea, Treatment of Glioma by Engineered Interleukin 4-secreting Cells Cancer Research. ,vol. 53, pp. 3125- 3128 ,(1993)
Takamitsu Fujimaki, Corazon D. Bucana, Ruo Dan Zhang, Janet E. Price, Isaiah J. Fidler, Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice. American Journal of Pathology. ,vol. 141, pp. 1115- 1124 ,(1992)
E. P. Cohen, E. F. De Zoeten, V. Carr-Brendel, Resistance to Melanoma in Mice Immunized with Semiallogeneic Fibroblasts Transfected with DNA from Mouse Melanoma Cells Journal of Immunology. ,vol. 160, pp. 2915- 2922 ,(1998)
George R. Birchfield, George M. Rodgers, Kenneth W. Girodias, John H. Ward, Wolfram E. Samlowski, Hypoprothrombinemia associated with interleukin-2 therapy: correction with vitamin K. Journal of Immunotherapy. ,vol. 11, pp. 71- 75 ,(1992) , 10.1097/00002371-199201000-00009
Steven A Rosenberg, James C Yang, Suzanne L Topalian, Douglas J Schwartzentruber, Jeffrey S Weber, David R Parkinson, Claudia A Seipp, Jan H Einhorn, Donald E White, Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 2 JAMA. ,vol. 271, pp. 907- 913 ,(1994) , 10.1001/JAMA.1994.03510360033032